Intranasal CGRP Antagonist Is Approved for the Treatment of Acute MigrainesByKyle Semmel, PharmD candidate,Colin Schleicher, PharmD candidate July 20th 2023Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.